Owlet (OWLT) Cash from Investing Activities (2020 - 2026)
Owlet (OWLT) posted quarterly Cash from Investing Activities of -$415000.0 for Q1 2026, down 277.27% year-over-year from $234102.6 in Q1 2025, and up 15.13% quarter-over-quarter from -$489000.0 in Q4 2025.
Owlet (OWLT) Cash from Investing Activities (2020 - 2026) Analysis & Trends
Owlet (OWLT) has reported Cash from Investing Activities for 7 consecutive years, with -$415000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 277.27% year-over-year to -$415000.0; the TTM figure through Mar 2026 stood at -$1.2 million (down 49.64% YoY), while the FY2025 annual figure was -$943000.0, down 23.92% from the prior year.
- Cash from Investing Activities grew to -$415000.0 in Q1 2026 per OWLT's latest filing, from -$489000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$8000.0 in Q1 2023 and bottomed at -$700000.0 in Q1 2022.
- Historically, Cash from Investing Activities has averaged -$220176.5 across 5 years, with a median of -$160000.0 in 2022.
- Annual changes were most pronounced in 2023 — Cash from Investing Activities surged 98.86% — and 2024, when it plunged 4563.64%.
- Owlet's Cash from Investing Activities stood at -$162000.0 in 2022, then surged by 82.1% to -$29000.0 in 2023, then tumbled by 500.0% to -$174000.0 in 2024, then sank by 181.03% to -$489000.0 in 2025, then rose by 15.13% to -$415000.0 in 2026.
- Business Quant data shows OWLT's Cash from Investing Activities at -$415000.0 in Q1 2026, -$489000.0 in Q4 2025, and -$255000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Owlet | 159.40 Mn | 122.85 Mn | 21.82 Mn | -941,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -941,000.00 |
| Jun 30, 2026 | -941,000.00 |
| Mar 31, 2026 | -415,000.00 |
| Mar 31, 2026 | -415,000.00 |
| Dec 31, 2025 | -489,000.00 |
| Dec 31, 2025 | -489,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Sep 30, 2025 | -255,000.00 |
| Jun 30, 2025 | -89,000.00 |
| Jun 30, 2025 | -89,000.00 |
| Mar 31, 2025 | -110,000.00 |
| Mar 31, 2025 | -110,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Sep 30, 2024 | -513,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |